Tezosentan
Tezosentan Uses, Dosage, Side Effects, Food Interaction and all others data.
Tezosentan is an intravenous endothelin receptor A/B antagonist. Tezosentan was initially developed for vasodilation in patients with acute heart failure but studies have shown that it does not assist in the treatment of dyspnea or prevent cardiovascular events.
Trade Name | Tezosentan |
Generic | Tezosentan |
Tezosentan Other Names | Tezosentan |
Type | |
Formula | C27H27N9O6S |
Weight | Average: 605.625 Monoisotopic: 605.180500331 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in congestive heart failure, liver disease, and heart disease.
Half Life
A pronounced and rapid disposition phase (half-life 6 min), accounting for the major part of the elimination, was followed by a slower phase (half-life 3 h), probably caused by distribution from tissues.
Innovators Monograph
You find simplified version here Tezosentan